There are 2789 resources available
1068P - Efficacy of combined hypo-fractionated radiotherapy (RT) in anti-PD-1 monotherapy-treated melanoma pts
Presenter: Philippe Saiag
Session: ePoster Display
1070P - Adjuvant treatment for melanoma in clinical practice: Trial versus reality
Presenter: Melissa De Meza
Session: ePoster Display
1071P - A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients
Presenter: Eva Ellebaek
Session: ePoster Display
1072P - Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
Presenter: Emilia Cocorocchio
Session: ePoster Display
1073P - Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial
Presenter: Sapna Patel
Session: ePoster Display
1074P - Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
Presenter: Michele Del Vecchio
Session: ePoster Display
1075P - Regression tree analysis to identify factors associated with relapse-free survival (RFS) in patients with resected stage III BRAF V600E/K–mutant melanoma
Presenter: Caroline Robert
Session: ePoster Display
1076P - Real-world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group study
Presenter: Mehmet Alpaslan Ozgun
Session: ePoster Display
1077P - Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy: A systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE)
Presenter: Georgina Long
Session: ePoster Display